REFERENCES
- Nathan, H.; Aloia, T.A.; Vauthey, J.N.; Abdalla, E.K.; Zhu, A.X.; Schulick, R.D.; Choti, M.A.; Pawlik, T.M. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009, 16(1), 14–22.
- Patel, T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006, 3(1), 33–42.
- Sano, T.; Shimada, K.; Sakamoto, Y.; Yamamoto, J.; Yamasaki, S.; Kosuge, T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 2006, 244(2), 240–247.
- Yamashita, Y.; Taketomi, A.; Morita, K.; Fukuhara, T.; Ueda, S.; Sanefuji, K.; The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 2008, 28(4C), 2353–2359.
- Nakagohri, T.; Kinoshita, T.; Konishi, M.; Takahashi, S.; Gotohda, N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 2008, 32(12), 2675–2680.
- Chiang, A.C.; Massague, J. Molecular basis of metastasis. N Engl J Med 2008, 359(26), 2814–2823.
- Simpson, C.D.; Anyiwe, K.; Schimmer, A.D. Anoikis resistance and tumor metastasis. Cancer Lett 2008, 272(2), 177–185.
- Eccles, S.A.; Welch, D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007, 369(9574), 1742–1757.
- Preet, A.; Ganju, R.K.; Groopman, J.E. Delta9-tetrahydroca-nnabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 2008, 27(3), 339–346.
- Leelawat, K.; Leelawat, S.; Narong, S.; Hongeng, S. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol 2007, 13(10), 1561–1568.
- Leelawat, K.; Narong, S.; Udomchaiprasertkul, W.; Leelawat, S.; Tungpradubkul, S. Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. Cancer Cell Int 2009, 9, 3.
- Kim, M.J.; Oh, D.Y.; Lee, S.H.; Kim, D.W.; Im, S.A.; Kim, T.Y.; Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study. BMC Cancer 2008, 8, 374.
- Guzman, M. Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003, 3(10), 745–755.
- Jia, W.; Hegde, V.L.; Singh, N.P.; Sisco, D.; Grant, S.; Nagarkatti, M.; Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of bad to mitochondria. Mol Cancer Res 2006, 4(8), 549–562.
- DeMorrow, S.; Francis, H.; Gaudio, E.; Venter, J.; Franchitto, A.; Kopriva, S.; The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 2008, 295(6), G1150–G1158.
- Rattanasinganchan, P.; Leelawat, K.; Treepongkaruna, S.A.; Tocharoentanaphol, C.; Subwongcharoen, S.; Suthiphongchai, T.; Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J Gastroenterol 2006, 12(40), 6500–6506.
- Greenhough, A.; Patsos, H.A.; Williams, A.C.; Paraskeva, C. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 2007, 121(10), 2172–2180.
- Grant, S. Cotargeting survival signaling pathways in cancer. J Clin Invest 2008, 118(9), 3003–3006.
- Steelman, L.S.; Abrams, S.L.; Whelan, J.; Bertrand, F.E.; Ludwig, D.E.; Basecke, J.; Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia 2008, 22(4), 686–707.
- Lambrechts, A.; Van Troys, M.; Ampe, C. The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 2004, 36(10), 1890–1909.
- Blazquez, C.; Salazar, M.; Carracedo, A.; Lorente, M.; Egia, A.; Gonzalez-Feria, L.; Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res 2008, 68(6), 1945–1952.
- Jiang, K.; Sun, J.; Cheng, J.; Djeu, J.Y.; Wei, S.; Sebti, S. Akt mediates ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol Cell Biol 2004, 24(12), 5565–5576.
- Bifulco, M.; Malfitano, A.M.; Pisanti, S.; Laezza, C. Endocannabinoids in endocrine and related tumours. Endocr Relat Cancer 2008, 15(2), 391–408.
- Guzman, M.; Duarte, M.J.; Blazquez, C.; Ravina, J.; Rosa, M.C.; Galve-Roperh, I.; A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 2006, 95(2), 197–203.